Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Shares Outstanding (Diluted Average) (2020 - 2025)

Adma Biologics' Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $244.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 0.64% year-over-year to $244.9 million; the TTM value through Dec 2025 reached $244.9 million, up 0.64%, while the annual FY2025 figure was $244.9 million, 0.64% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $244.9 million in Q4 2025 per ADMA's latest filing, roughly flat from $245.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $248.6 million in Q2 2025 to a low of $115.7 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $207.5 million, with a median of $223.1 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 69.35% in 2022, then grew 0.28% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $139.6 million in 2021, then soared by 41.77% to $197.9 million in 2022, then grew by 13.19% to $224.0 million in 2023, then grew by 8.65% to $243.3 million in 2024, then increased by 0.64% to $244.9 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Shares Outstanding (Diluted Average) are $244.9 million (Q4 2025), $245.5 million (Q3 2025), and $248.6 million (Q2 2025).